Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

BACKGROUND & AIMS: Patients with Crohn’s disease (CD), but not ulcerative colitis (UC), of shorter duration have higher rates of response to tumor necrosis factor (TNF) antagonists than patients with longer disease duration. Little is known about the association between disease duration and resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Faleck, David M., Winters, Adam, Chablaney, Shreya, Shashi, Preeti, Meserve, Joseph, Weiss, Aaron, Aniwan, Satimai, Koliani-Pace, Jenna L., Kochhar, Gursimran, Boland, Brigid S., Singh, Siddharth, Hirten, Robert, Shmidt, Eugenia, Kesar, Varun, Lasch, Karen, Luo, Michelle, Bohm, Matthew, Varma, Sashidhar, Fischer, Monika, Hudesman, David, Chang, Shannon, Lukin, Dana, Sultan, Keith, Swaminath, Arun, Gupta, Nitin, Siegel, Corey A., Shen, Bo, Sandborn, William J., Kane, Sunanda, Loftus, Edward V., Sands, Bruce E., Colombel, Jean-Frederic, Dulai, Parambir S., Ungaro, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026826/
https://www.ncbi.nlm.nih.gov/pubmed/30625408
http://dx.doi.org/10.1016/j.cgh.2018.12.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026826/
https://www.ncbi.nlm.nih.gov/pubmed/30625408
http://dx.doi.org/10.1016/j.cgh.2018.12.040

Ejemplares similares